title: Anticoagulant therapy: Is there always a best choice?
authors.affiliation: Cardiology Unit, Emergency Dept, Hospital "Madonna del Soccorso", San Benedetto del Tronto, Italy.
authors.forename: C
authors.initials: C
authors.lastname: Consorti
authors.affiliation: Hospital "Busto Arsizio", Varese, Italy.
authors.forename: A M
authors.initials: AM
authors.lastname: Cotruzzola
authors.affiliation: Hospital "Sant'Antonio Abate di Gallarate", Varese, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Bruno
authors.affiliation: Cardiology Unit, Emergency Dept, Hospital "Madonna del Soccorso", San Benedetto del Tronto, Italy. Electronic address: michelescarano1978@gmail.com.
authors.forename: M
authors.initials: M
authors.lastname: Scarano
mesh_terms: D000368:Aged; D000925:Anticoagulants / Q000008:administration & dosage* / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000000981:diagnostic imaging / Q000188:drug therapy*; D001247:Asthenia / Q000209:etiology*; D002755:Choice Behavior; D019468:Disease Management; D000077425:Fondaparinux; D006493:Heparin / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D008297:Male; D011134:Polysaccharides / Q000008:administration & dosage / Q000627:therapeutic use; D000069552:Rivaroxaban / Q000008:administration & dosage / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000925:Anticoagulants; D011134:Polysaccharides; D006493:Heparin; D000069552:Rivaroxaban; D000077425:Fondaparinux